SCHEMBL19959910

SCHEMBL19959910

O=P(c1ccc2ccccc2c1)(c1cnc2ccccc2c1)c1cccc2c1nc1c3ccccc3c3ccccc3n21

nearest known ligand 0.34

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
USP2 O75604 2/20 0.34
ALDH1A1 P00352 2/20 0.34
LMNA P02545 1/20 0.34
GAA P10253 1/20 0.34
TSHR P16473 1/20 0.34
SLC40A1 Q9NP59 1/20 0.31
KDR P35968 1/20 0.31
NPC1 O15118 2/20 0.30
RAB9A P51151 2/20 0.30
SMN1; SMN2 Q16637 2/20 0.30
HSD17B10 Q99714 2/20 0.30
KDM4E B2RXH2 1/20 0.30
TP53 P04637 1/20 0.30
CYP1A2 P05177 1/20 0.30
CYP2D6 P10635 1/20 0.30
THRB P10828 1/20 0.30
HPGD P15428 1/20 0.30
MAPK1 P28482 1/20 0.30
TNKS O95271 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22166874 0.94 TOP1 (0.31) USP2ALDH1A1LMNAGAATSHR
SCHEMBL19959862 0.93 TOP1 (0.35) USP2ALDH1A1LMNAGAATSHR
SCHEMBL19959819 0.93 SLC40A1 (0.34) ALDH1A1SLC40A1
SCHEMBL19959815 0.92 POLB (0.33) USP2ALDH1A1LMNAGAATSHR
SCHEMBL19959925 0.89 ALDH1A1 (0.34) USP2ALDH1A1LMNAGAATSHR
SCHEMBL19959775 0.88 TOP1 (0.37) USP2ALDH1A1LMNAGAATSHR
SCHEMBL19959870 0.87 ALDH1A1 (0.33) ALDH1A1LMNAHSD17B10KDM4ECYP1A2
SCHEMBL19959909 0.87 USP2 (0.31) USP2ALDH1A1LMNAGAATSHR
SCHEMBL19959921 0.85 KDM4E (0.35) USP2ALDH1A1LMNAGAATSHR
SCHEMBL19959932 0.85 ALDH1A1 (0.33) USP2ALDH1A1LMNAGAATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10700289-B2 Heterocyclic compound and organic light emitting element comprising same LG CHEM, LTD. (KR) 2020-06-30 US disclosed
US-20180076395-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-03-15 US disclosed
US-20180076395-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-03-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180076395-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME CRY1, CRY2, PER2 USP2 2746/4885ALDH1A1 750/4885LMNA 3023/4885
US-10700289-B2 Heterocyclic compound and organic light emitting element comprising same CRY1, CRY2, PER2 USP2 2746/4885ALDH1A1 750/4885LMNA 3023/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.